Received Jul 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 7NX57 | IM / RA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 42DM9 | IM / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y020299 | SC / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8361AA | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | X449Y | IM / RA |
Inadvertently gave MMRV to client instead of administering separately an MMR vaccine and a Varicella vaccine. Client was verbally informed of the error and instructed to return to the health clinic in one month to receive the two requested vaccines (MMR & VAR). Client was observed and showed no adverse effects. Client was provided a current vaccine record which listed the administration of the combination vaccine (MMRV).
None indicated by patient
None indicated by patient
None indicated by patient
None indicated by patient